What's Happening?
ViiV Healthcare, a global specialist HIV company majority owned by GSK, has launched a social media video campaign titled 'Still Here' to coincide with National Youth HIV/AIDS Awareness Day. The campaign aims to spark crucial conversations about HIV among
young people, highlighting the ongoing public health issue that HIV presents, particularly among youth. Despite progress in HIV prevention and care, young people aged 13-24 account for nearly 20% of new HIV diagnoses nationwide, with a significant portion never having been tested for HIV. The campaign seeks to raise awareness of HIV incidence and promote education around pre-exposure prophylaxis (PrEP) and HIV care, especially among disproportionately impacted groups such as Black youth.
Why It's Important?
The 'Still Here' campaign is crucial in addressing the gap in HIV awareness and testing among young people, who are often unaware of prevention and treatment options. By targeting this demographic, ViiV Healthcare aims to reduce the incidence of HIV and improve health outcomes through education and dialogue. The campaign also emphasizes the importance of community engagement and tailored communication strategies to connect with young audiences effectively. As the pioneer of long-acting injectables for HIV, ViiV Healthcare's initiative reflects its commitment to transforming HIV care and working towards an HIV-free generation.
What's Next?
ViiV Healthcare plans to continue its efforts to engage young people in meaningful dialogue about HIV prevention and care. The 'Still Here' campaign is part of a broader strategy to integrate community voices and scientific advancements in HIV treatment. ViiV Healthcare will likely expand its outreach and educational initiatives to further raise awareness and encourage testing among youth. The company may also collaborate with other organizations and stakeholders to amplify its message and drive action towards reducing HIV incidence among young people.
